Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Azitra Inc

AZTR
0,152
-0,0131 (-7,93%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:38:33
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
31/5/202414:00BWAzitra, Inc. Announces Presentation at the 2024 BIO..
24/5/202422:55EDGAR2Form PRE 14A - Other preliminary proxy statements
17/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data from ATR-04..
10/5/202414:00BWAzitra, Inc. Announces Positive Preclinical Data of ATR-12..
09/5/202423:05EDGAR2Form 8-K - Current report
09/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202423:00BWAzitra, Inc. Announces Q1 2024 Financial Results and..
22/4/202422:30BWAzitra, Inc. Announces New Preclinical Data to be Presented..
18/4/202422:15BWAzitra, Inc. to Present New Data at Three Upcoming..
15/3/202421:15BWAzitra, Inc. Announces Full Year 2023 Financial Results and..
26/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/2/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/2/202422:05BWAzitra, Inc. Announces Closing of Public Offering
16/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202415:15EDGAR2Form 8-K - Current report
14/2/202404:09BWAzitra, Inc. Announces Pricing of Public Offering
19/1/202417:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
19/1/202415:19EDGAR2Form S-1 - General form for registration of securities under..
16/1/202415:00BWAzitra, Inc. Strengthens Intellectual Property Portfolio..
03/1/202415:00BWAzitra, Inc. to Present at Biotech Showcase 2024 and the..
04/12/202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202322:30BWAzitra, Inc. Announces Third Quarter 2023 Financial Results..
16/10/202314:00BWAzitra to Present at the ThinkEquity Conference
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202314:00PRNUSAzitra to Present at the H.C. Wainwright 25th Annual Global..
14/8/202322:11EDGAR2Form 8-K - Current report
14/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05PRNUSAzitra, Inc. Announces Second Quarter 2023 Financial Results..
19/7/202322:05PRNUSAzitra Adds Biotech Leaders Barbara Ryan and John Schroer to..
11/7/202322:05EDGAR2Form 8-K - Current report
11/7/202322:05PRNUSAzitra, Inc. Appoints Travis Whitfill as Chief Operating..
07/7/202322:05EDGAR2Form 8-K - Current report
03/7/202321:04EDGAR2Form SC 13D - General statement of acquisition of beneficial..
29/6/202322:56EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
22/6/202300:46PRNUSAzitra, Inc. Announces Closing of Initial Public Offering
16/6/202301:04PRNUSAzitra, Inc. Announces Pricing of Initial Public Offering
Apertura: 0,165 Min: 0,1491 Max: 0,1708
Chiusura: 0,1651

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network